Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty

Category: Ankle, Basic Sciences/Biologics Introduction/Purpose: Subchondroplasty® (SCP®) (Zimmer Holdings, Inc, Warsaw, IN) is a relatively new procedure that was developed in 2007 for the treatment of bone-marrow lesions (BMLs). It involves the injection of flowable nanocrystalline calcium phosphat...

Full description

Bibliographic Details
Main Authors: Andrew Hanselman MD, Elizabeth Cody MD, Mark Easley MD, Samuel Adams MD, Selene Parekh MD, MBA
Format: Article
Language:English
Published: SAGE Publishing 2019-10-01
Series:Foot & Ankle Orthopaedics
Online Access:https://doi.org/10.1177/2473011419S00198
_version_ 1818974483938017280
author Andrew Hanselman MD
Elizabeth Cody MD
Mark Easley MD
Samuel Adams MD
Selene Parekh MD, MBA
author_facet Andrew Hanselman MD
Elizabeth Cody MD
Mark Easley MD
Samuel Adams MD
Selene Parekh MD, MBA
author_sort Andrew Hanselman MD
collection DOAJ
description Category: Ankle, Basic Sciences/Biologics Introduction/Purpose: Subchondroplasty® (SCP®) (Zimmer Holdings, Inc, Warsaw, IN) is a relatively new procedure that was developed in 2007 for the treatment of bone-marrow lesions (BMLs). It involves the injection of flowable nanocrystalline calcium phosphate (CaP) synthetic bone substitute into the BML using fluoroscopic-guidance, in order to promote healing and reinforce the effected region. Although a newer technique, SCP has been shown promising results in the knee through several different small case-series. The foot and ankle literature is sparser, with only a few documented case-reports or case-series. As a result, we wanted to report our small case-series of patients who underwent talar SCP and went on to develop avascular necrosis (AVN). Methods: A retrospective review was conducted of patients who underwent SCP for a talar BML at our facility or were referred to our facility after undergoing SCP at an outside institution. Patients who developed iatrogenic talar AVN postoperatively were included in the study. Patient characteristics, comorbidities, imaging, and need for further surgery was analyzed. Results: Four patients were identified who had previously undergone talar SCP and went on to develop iatrogenic talar AVN. Two patients had their original SCP performed at our facility, whereas the other two patients were referred from outside institutions. All four patients were symptomatic from their AVN. Two patients have undergone revision surgical intervention, while the other two patients are pending surgical intervention. Conclusion: This case-series is the first study, to our knowledge, to report iatrogenic talar AVN after undergoing SCP for talar BMLs. Although early studies in the Foot and Ankle literature are promising for use of this technology, these studies have been small and surgeons should be aware of this potential complication.
first_indexed 2024-12-20T15:40:47Z
format Article
id doaj.art-480b69dc73454a8b8a394d76354e85fe
institution Directory Open Access Journal
issn 2473-0114
language English
last_indexed 2024-12-20T15:40:47Z
publishDate 2019-10-01
publisher SAGE Publishing
record_format Article
series Foot & Ankle Orthopaedics
spelling doaj.art-480b69dc73454a8b8a394d76354e85fe2022-12-21T19:35:11ZengSAGE PublishingFoot & Ankle Orthopaedics2473-01142019-10-01410.1177/2473011419S00198Iatrogenic Avascular Necrosis of the Talus Following SubchondroplastyAndrew Hanselman MDElizabeth Cody MDMark Easley MDSamuel Adams MDSelene Parekh MD, MBACategory: Ankle, Basic Sciences/Biologics Introduction/Purpose: Subchondroplasty® (SCP®) (Zimmer Holdings, Inc, Warsaw, IN) is a relatively new procedure that was developed in 2007 for the treatment of bone-marrow lesions (BMLs). It involves the injection of flowable nanocrystalline calcium phosphate (CaP) synthetic bone substitute into the BML using fluoroscopic-guidance, in order to promote healing and reinforce the effected region. Although a newer technique, SCP has been shown promising results in the knee through several different small case-series. The foot and ankle literature is sparser, with only a few documented case-reports or case-series. As a result, we wanted to report our small case-series of patients who underwent talar SCP and went on to develop avascular necrosis (AVN). Methods: A retrospective review was conducted of patients who underwent SCP for a talar BML at our facility or were referred to our facility after undergoing SCP at an outside institution. Patients who developed iatrogenic talar AVN postoperatively were included in the study. Patient characteristics, comorbidities, imaging, and need for further surgery was analyzed. Results: Four patients were identified who had previously undergone talar SCP and went on to develop iatrogenic talar AVN. Two patients had their original SCP performed at our facility, whereas the other two patients were referred from outside institutions. All four patients were symptomatic from their AVN. Two patients have undergone revision surgical intervention, while the other two patients are pending surgical intervention. Conclusion: This case-series is the first study, to our knowledge, to report iatrogenic talar AVN after undergoing SCP for talar BMLs. Although early studies in the Foot and Ankle literature are promising for use of this technology, these studies have been small and surgeons should be aware of this potential complication.https://doi.org/10.1177/2473011419S00198
spellingShingle Andrew Hanselman MD
Elizabeth Cody MD
Mark Easley MD
Samuel Adams MD
Selene Parekh MD, MBA
Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty
Foot & Ankle Orthopaedics
title Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty
title_full Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty
title_fullStr Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty
title_full_unstemmed Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty
title_short Iatrogenic Avascular Necrosis of the Talus Following Subchondroplasty
title_sort iatrogenic avascular necrosis of the talus following subchondroplasty
url https://doi.org/10.1177/2473011419S00198
work_keys_str_mv AT andrewhanselmanmd iatrogenicavascularnecrosisofthetalusfollowingsubchondroplasty
AT elizabethcodymd iatrogenicavascularnecrosisofthetalusfollowingsubchondroplasty
AT markeasleymd iatrogenicavascularnecrosisofthetalusfollowingsubchondroplasty
AT samueladamsmd iatrogenicavascularnecrosisofthetalusfollowingsubchondroplasty
AT seleneparekhmdmba iatrogenicavascularnecrosisofthetalusfollowingsubchondroplasty